I-Sichuan Deebio Pharmaceutical Co., Ltd yamkele uhlolo lokuthotyelwa kwe-GMP olusemthethweni olusuka eJapan PMDA ukusuka kwi-8.25 ukuya kwi-8.26 ngo-2022. Iqela lophicotho lwe-GMP libandakanya abaphicothi-zincwadi ababini abakhokelwa ngamagqala eengcali anamava kwaye baqhuba uphicotho lweentsuku ezimbini bekude.Iingcali zeqela lokuhlola zenze uhlolo olubanzi lwenkqubo yokulawula umgangatho we-Deebio, inkqubo yokulawula imveliso, ukusebenza kwendawo, ulawulo lwebhubhoratri, izibonelelo ezixhasayo ezinxulumene nezixhobo kunye nokugcinwa kweenkqubo zoluntu.

Ngohlolo, iingcali zeqela lokuhlola ziye zaqinisekisa ngamxhelomnye kwaye zayamkela inkqubo yolawulo lomgangatho we-GMP kaDeebio.Okokugqibela, u-Deebio uphumelele ngempumelelo isiqinisekiso se-GMP se-PMDA yaseJapan!

I-PMDA (i-Arhente ye-Pharmaceuticals kunye ne-Medical Devices Agency) yi-arhente yaseJapan ejongene nokuphononongwa kobugcisa bamachiza kunye nezixhobo zonyango.Isebenza ngokufana ne-FDA e-United States kunye ne-NMPA e-China.

I-Deebio iphumelele i-EU-GMP kunye ne-Chinese GMP isatifikethi.Ukupasa ngempumelelo isiqinisekiso se-PMDA yaseJapan kuphawula uloyiso olunezigaba kwisicwangciso sehlabathi sika-Deebio!